DK1572622T3 - Anvendelse af levalbuterol-L-tartrat ved fremstilling af en doseringsinhalator - Google Patents

Anvendelse af levalbuterol-L-tartrat ved fremstilling af en doseringsinhalator

Info

Publication number
DK1572622T3
DK1572622T3 DK03786896T DK03786896T DK1572622T3 DK 1572622 T3 DK1572622 T3 DK 1572622T3 DK 03786896 T DK03786896 T DK 03786896T DK 03786896 T DK03786896 T DK 03786896T DK 1572622 T3 DK1572622 T3 DK 1572622T3
Authority
DK
Denmark
Prior art keywords
levalbuterol
tartrate
preparation
dosage inhaler
inhaler
Prior art date
Application number
DK03786896T
Other languages
English (en)
Inventor
Roger Bakale
Paul Mcglynn
Craig Sturge
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32507867&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1572622(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sepracor Inc filed Critical Sepracor Inc
Application granted granted Critical
Publication of DK1572622T3 publication Critical patent/DK1572622T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/56—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups
    • C07C215/58—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups with hydroxy groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
    • C07C215/60—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups with hydroxy groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain the chain having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/002—Details of inhalators; Constructional features thereof with air flow regulating means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/255—Tartaric acid
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K3/00—Materials not provided for elsewhere
    • C09K3/30—Materials not provided for elsewhere for aerosols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0468—Liquids non-physiological
    • A61M2202/0484—Alcohol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0468—Liquids non-physiological
    • A61M2202/0488—Surfactant, e.g. for the lung
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Materials Engineering (AREA)
  • Dispersion Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
DK03786896T 2002-12-10 2003-12-08 Anvendelse af levalbuterol-L-tartrat ved fremstilling af en doseringsinhalator DK1572622T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43219502P 2002-12-10 2002-12-10

Publications (1)

Publication Number Publication Date
DK1572622T3 true DK1572622T3 (da) 2006-08-28

Family

ID=32507867

Family Applications (3)

Application Number Title Priority Date Filing Date
DK03786896T DK1572622T3 (da) 2002-12-10 2003-12-08 Anvendelse af levalbuterol-L-tartrat ved fremstilling af en doseringsinhalator
DK10176026.2T DK2292584T3 (da) 2002-12-10 2003-12-08 Farmaceutisk sammensætning omfattende levalbuterol L-hemitartratsalt som aerosolformulering
DK06110646.4T DK1671942T4 (da) 2002-12-10 2003-12-08 Aerosolformulering omfattende levalbuterol L-tartratsalt

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK10176026.2T DK2292584T3 (da) 2002-12-10 2003-12-08 Farmaceutisk sammensætning omfattende levalbuterol L-hemitartratsalt som aerosolformulering
DK06110646.4T DK1671942T4 (da) 2002-12-10 2003-12-08 Aerosolformulering omfattende levalbuterol L-tartratsalt

Country Status (19)

Country Link
US (8) US7256310B2 (da)
EP (3) EP2292584B1 (da)
JP (1) JP4570960B2 (da)
KR (3) KR101166955B1 (da)
AT (2) ATE498604T1 (da)
AU (1) AU2003295695B2 (da)
CA (1) CA2507572C (da)
CY (2) CY1106315T1 (da)
DE (2) DE60304900T2 (da)
DK (3) DK1572622T3 (da)
ES (3) ES2263051T3 (da)
IL (2) IL168739A (da)
MX (1) MXPA05006087A (da)
NO (1) NO331649B1 (da)
NZ (1) NZ541168A (da)
PL (1) PL212725B1 (da)
PT (3) PT1671942E (da)
SI (2) SI1572622T1 (da)
WO (1) WO2004052835A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6466862B1 (en) * 1999-04-19 2002-10-15 Bruce DeKock System for providing traffic information
US20070264202A1 (en) * 2004-09-09 2007-11-15 Cipla Limited Pharmaceutical Composition Comprising an Isomer of Betamimetic Agent and an Anti-Cholinergic Agent
KR20070100735A (ko) 2004-12-17 2007-10-11 씨아이피엘에이 엘티디. 약학적 화합물 및 조성물
RU2440972C2 (ru) 2004-12-17 2012-01-27 Сипла Лимитед Кристаллический сульфат левосальбутамола, способ его получения и фармацевтическая композиция, содержащая его
US8751589B2 (en) 2011-04-13 2014-06-10 Jingle Technologies Llc Systems and methods for transmitting information, alerts, and/or comments to participants based on location information
EP3042892A1 (en) 2015-01-09 2016-07-13 Deva Holding Anonim Sirketi Amorphisation of levosalbutamol tartrate
CN106727318A (zh) * 2016-12-22 2017-05-31 山东京卫制药有限公司 一种气雾剂及其制备方法
WO2021188809A1 (en) * 2020-03-19 2021-09-23 Cai Gu Huang Inhalable formulation of a solution containing levalbuterol tartrate

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1200886A (en) * 1966-09-23 1970-08-05 Allen & Hanburys Ltd Phenylaminoethanol derivatives
US5766573A (en) 1988-12-06 1998-06-16 Riker Laboratories, Inc. Medicinal aerosol formulations
US5225183A (en) 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
GB8828477D0 (en) † 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5345980A (en) 1989-09-21 1994-09-13 Glaxo Group Limited Method and apparatus an aerosol container
US5362755A (en) 1990-01-05 1994-11-08 Sepracor, Inc. Method for treating asthma using optically pure (R)-albuterol
US5255183A (en) * 1990-05-29 1993-10-19 Interactive Voice Data System Inc. Telephone-based personnel tracking system
EP1736147A3 (en) 1991-06-10 2007-10-17 Schering Corporation Non-chlorofluorocarbon aerosol formulations
EP0617610B1 (en) 1991-12-18 1997-03-19 Minnesota Mining And Manufacturing Company Suspension aerosol formulations
US5545745A (en) * 1994-05-23 1996-08-13 Sepracor, Inc. Enantioselective preparation of optically pure albuterol
US5399765A (en) 1994-05-23 1995-03-21 Sepracor, Inc. Enantioselective preparation of optically pure albuterol
ES2292526T3 (es) * 1995-04-14 2008-03-16 Smithkline Beecham Corporation Procedimiento para la preparacion de un inhalador dosificador.
US5603918A (en) 1995-06-09 1997-02-18 Boehringer Ingelheim Pharmaceuticals, Inc. Aerosol composition of a salt of ipratropium and a salt of albuterol
US6040344A (en) 1996-11-11 2000-03-21 Sepracor Inc. Formoterol process
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
GB9806462D0 (en) 1998-03-26 1998-05-27 Glaxo Group Ltd Improved compositions for inhalation
DE59911149D1 (de) * 1998-07-24 2004-12-30 Jago Res Ag Muttenz Medizinische aerosolformulierungen
ATE234604T1 (de) * 1998-08-04 2003-04-15 Jago Res Ag Medizinische aerosolformulierungen
EP1283036B2 (de) * 1998-11-13 2020-01-01 Jagotec AG Multidosis-Trockenpulverinhalator mit Pulverreservoir
CN1173929C (zh) 1999-10-19 2004-11-03 中国科学院成都有机化学研究所 光学纯肾上腺素类β-激动剂的组合拆分制备法
US6451289B2 (en) 2000-03-24 2002-09-17 Sepracor Inc. Albuterol formulations
GB0030171D0 (en) 2000-12-11 2001-01-24 Cipla Ltd Process for preparing isomers of salbutamol
CZ301676B6 (cs) * 2001-03-30 2010-05-19 Jagotec Ag Farmaceutický suspenzní aerosolový prípravek pro inhalaci a použití soli karboxylové kyseliny
DE10120531A1 (de) * 2001-04-26 2002-10-31 Basf Ag Neue Reaktivfarbstoffe und deren Verwendung zum Färben von Substraten, welche nucleophile Gruppen enthalten
CN1206205C (zh) 2001-04-26 2005-06-15 中国科学院成都有机化学研究所 R－沙丁胺醇酒石酸盐的制备方法

Also Published As

Publication number Publication date
JP4570960B2 (ja) 2010-10-27
US20100272654A1 (en) 2010-10-28
DE60336089D1 (de) 2011-03-31
KR20050088307A (ko) 2005-09-05
EP1572622A1 (en) 2005-09-14
PT1572622E (pt) 2006-08-31
US20080119564A1 (en) 2008-05-22
CY1111330T1 (el) 2015-08-05
IL168739A (en) 2011-06-30
WO2004052835A1 (en) 2004-06-24
EP1671942B2 (en) 2014-07-23
NO20053339L (no) 2005-09-07
IL212369A (en) 2013-08-29
US20130028845A1 (en) 2013-01-31
US20130236515A1 (en) 2013-09-12
US20150071969A1 (en) 2015-03-12
US8765153B2 (en) 2014-07-01
KR20080103614A (ko) 2008-11-27
US20040115136A1 (en) 2004-06-17
ATE324364T1 (de) 2006-05-15
CA2507572A1 (en) 2004-06-24
US20180222845A1 (en) 2018-08-09
DK2292584T3 (da) 2017-05-01
NO20053339D0 (no) 2005-07-08
ES2626648T3 (es) 2017-07-25
EP1671942A1 (en) 2006-06-21
ATE498604T1 (de) 2011-03-15
AU2003295695A1 (en) 2004-06-30
NO331649B1 (no) 2012-02-13
EP2292584B1 (en) 2017-03-01
EP1671942B1 (en) 2011-02-16
AU2003295695B2 (en) 2009-08-20
DE60304900T2 (de) 2006-10-19
PT2292584T (pt) 2017-06-12
PT1671942E (pt) 2011-05-11
US20160368858A1 (en) 2016-12-22
US7256310B2 (en) 2007-08-14
SI1572622T1 (sl) 2006-10-31
DE60304900D1 (de) 2006-06-01
EP1572622B1 (en) 2006-04-26
DK1671942T4 (da) 2014-09-22
ES2361172T3 (es) 2011-06-14
SI1671942T2 (sl) 2014-10-30
EP2292584A1 (en) 2011-03-09
KR101166955B1 (ko) 2012-07-19
CA2507572C (en) 2011-04-19
MXPA05006087A (es) 2005-09-30
DK1671942T3 (da) 2011-04-26
ES2263051T3 (es) 2006-12-01
CY1106315T1 (el) 2011-10-12
KR20100080865A (ko) 2010-07-12
NZ541168A (en) 2008-10-31
PL377336A1 (pl) 2006-01-23
ES2361172T5 (es) 2014-09-22
SI1671942T1 (sl) 2011-04-29
PL212725B1 (pl) 2012-11-30
JP2006509802A (ja) 2006-03-23
IL212369A0 (en) 2011-06-30

Similar Documents

Publication Publication Date Title
AU2003286786A1 (en) Increased dosage metered dose inhaler
PL369072A1 (en) Metered dose inhaler
NO20032836D0 (no) Utmålt-dose-inhalator for salmeterol-xinafoat
EA200601837A1 (ru) Бензоксазины для лечения заболеваний дыхательных путей
DE60224111D1 (de) Bausatz zur Herstellung einer Verabreichungsform zur Abgabe einer bioaktiven Substanz
IL183506A (en) Use of a compound for the preparation of a drug for the treatment of diseases of breast tumors
BRPI0417717A (pt) composto, composição farmacêutica, e, uso de um composto
NO20053339D0 (no) Levalbuterolsalt.
EA200602016A1 (ru) ПОРОШКОВЫЕ КОМПОЗИЦИИ ДЛЯ ИНГАЛЯЦИИ, СОДЕРЖАЩИЕ ЭНАНТИОМЕРНОЧИСТЫЕ β-АГОНИСТЫ
BRPI0507225A2 (pt) formulações estáveis de solução farmacêutica para inaladores pressurizados de dose medida
ATE499939T1 (de) Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend
DK1283708T3 (da) Anvendelse af biguanidderivater til fremstilling af et medikament med sårhelingsvirkning
GB0328630D0 (en) Metered dose inhalation preparations
NZ528164A (en) Use of flumazenil to produce a medicament for the treatment of cocaine dependency
DK1641508T3 (da) Inhalator til flere doser
EA200501565A1 (ru) Предназначенная для перорального приёма лекарственная форма для антагонистов протонного насоса
DE60114597D1 (de) Naphthamid-neurokinin antagonisten zur verwendung als medikamente
HK1103280A1 (en) Stable pharmaceutical solution formulations for pressurized metered dose inhalers
RS52038B (en) USE OF 7-BUTOXYIMINOMETHYLAMPTOTECIN FOR THE TREATMENT OF NON-PLASMA NEOPLASMS
GB0328629D0 (en) Metered dose inhalation preparations
GB0314727D0 (en) Spacers for use with metered dose inhalers
GB0226274D0 (en) Metered dose inhalation preparations
ATE493976T1 (de) Bakuchiol enthaltende pharmazeutische zusammensetzung zur behandlung von weiblicher osteoporose
AU2002236091A1 (en) Canisters for use in metered dose inhalers
GB0018675D0 (en) Metered dose inhaler